| Financial Year |
March 31 2023 |
| Monetary Funds |
3,078,326,799.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,672,297,437.02 |
| Advances to Suppliers |
1,419,993,163.54 |
| Other Receivables |
106,514,277.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
9,742,664.37 |
| Inventories |
772,422,389.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,136,279.90 |
| Other Current Assets |
259,230,557.83 |
| Total Current Assets |
7,349,878,559.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
37,400,000.00 |
| Long-term Equity Investment |
376,661,877.17 |
| Investment Properties |
9,735,111.72 |
| Fixed Assetes |
18,955,558,615.37 |
| Under-construction Projects |
1,414,093,385.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,280,261,743.96 |
| R&D expenses |
790,358.47 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
532,466.47 |
| Deferred Income Tax Assets |
649,126,329.65 |
| Other Non-Current Assets |
208,232,422.15 |
| Sub-Total of Non-Current Assets |
23,044,718,503.39 |
| Total Assets |
30,394,597,062.89 |
| Short-Term Loans |
3,960,876,257.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,577,531,267.88 |
| Accounts Payable |
1,684,096,365.27 |
| Accounts Received In Advance |
2,837.10 |
| Employee Compensation Payable |
111,453,019.51 |
| Taxes Payable |
32,433,253.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
506,354,594.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,931,805,447.40 |
| Other Current Liabilities |
531,001,303.80 |
| Sub-Total of Current Liabilities |
10,412,227,583.02 |
| Long-term Loans |
13,748,728,728.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,445,679,352.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,169,010.86 |
| Other Non-Current Liabilities |
69,414,872.70 |
| Sub-Total of Non-Current Liabilities |
16,413,418,486.49 |
| Total Liabilities |
26,825,646,069.51 |
| Paid-In Capital(Or Share Stock) |
1,525,781,330.00 |
| Capital Surplus |
6,529,525,048.95 |
| Surplus Reserve |
183,737,055.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,914,025,840.36 |
| Minority Stockholder's Interest |
216,311,599.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,352,639,394.34 |
| Owner's Equity（Stockholder's Equity） |
3,568,950,993.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,394,597,062.89 |
